GlobeNews Wire

Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum

Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from operations reduced to $5.4 million vs $8.6 million…

8 months ago

IPSEN – Buy-back programme – Art 5 of MAR – Week 33 – 2025

Aggregated presentation by day and by marketStatement of transactions in own shares from August 11th to August 15th 2025       Name of…

8 months ago

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 18, 2025 16:35 ET  | Source: Vor Biopharma CAMBRIDGE, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq:…

8 months ago

Invivyd Announces Continued Neutralizing Activity of PEMGARDA (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (Stratus)

August 18, 2025 16:32 ET  | Source: Invivyd New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA® (pemivibart)…

8 months ago

Eagle Pharmaceuticals Announces 2025 Annual Meeting Date

WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced…

8 months ago

SOVRA Sharpens Focus on GovTech Sector with Series of Strategic Updates

MONTREAL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- SOVRA (formerly mdf commerce) ("SOVRA" or "the Company"), North America’s leading public sector…

8 months ago

Key Labs accelerates crypto token growth with advanced market making, algorithmic trading strategies & liquidity solutions

LONDON, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Key Labs, a boutique provider of crypto market making services and strategic growth…

8 months ago

Elyor Platform: Market Experts & Traders Discuss Elyor Platform For Its Cutting-Edge AI, Security, and Performance Metrics – Read Australia Trading Report!

New York City, NY, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Introduction: Elyor Platform in the 2025 Global Trading Landscape In…

8 months ago

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial…

8 months ago

InnovAge Florida PACE Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa

TAMPA, Fla., Aug. 15, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leader in senior care through…

8 months ago